Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
This report contains market size and forecasts of Purpura Therapy Drugs in global, including the following market information:
Global Purpura Therapy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Purpura Therapy Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Purpura Therapy Drugs companies in 2021 (%)
The global Purpura Therapy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allergic Purpura Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Purpura Therapy Drugs include Bristol-Myers Squibb Company, Pfizer Inc, GlaxoSmithKline Plc, Novartis AG, Hovione, Sanofi Winthrop Industrie S.A., Hoffman-L Roche, Amgen Inc and Grifols Biologicals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Purpura Therapy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Purpura Therapy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Purpura Therapy Drugs Market Segment Percentages, by Type, 2021 (%)
Allergic Purpura
Thrombocytopenic Purpura
Global Purpura Therapy Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Purpura Therapy Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Use
Clinic Use
Household
Other
Global Purpura Therapy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Purpura Therapy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Purpura Therapy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Purpura Therapy Drugs revenues share in global market, 2021 (%)
Key companies Purpura Therapy Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Purpura Therapy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee's Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch